Francheska Colón‐González

768 citations

19 papers · 596 indexed · h-index 12

Applied Microbiology and Biotechnology top 10%
- Antibiotic Use and Resistance 2
Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 3
Endocrine and Autonomic Systems
- Regulation of Appetite and Obesity 3
Cell Biology
Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacology and Obesity Treatment 2
Epidemiology
- Pneumonia and Respiratory Infections 2
Cancer Research
- Cancer, Hypoxia, and Metabolism 2
Physiology
- Diet and metabolism studies 2

Co-authors: Marcelo G. Kazanietz Jieru E. Lin Scott A. Waldman Gilbert W. Kim Michael Valentino Walter K. Kraft Dennis E. Discher Thomas D. Dziubla
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Endocrine and Autonomic Systems
Journals: Antimicrobial Agents and Chemotherapy (2 papers)Journal of Biological Chemistry (2 papers)Cancer Research (2 papers)
Partner nations: United States China Netherlands

In The Last Decade

Francheska Colón‐González

18 papers receiving 584 citations

Peers

Countries citing papers authored by Francheska Colón‐González

Since Specialization

Citations

This map shows the geographic impact of Francheska Colón‐González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francheska Colón‐González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francheska Colón‐González more than expected).

Fields of papers citing papers by Francheska Colón‐González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francheska Colón‐González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francheska Colón‐González. The network helps show where Francheska Colón‐González may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Francheska Colón‐González, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Francheska Colón‐González Line = papers co-authored together Francheska Colón‐González links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	A single- and multiple-dose study to characterize the pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Chinese participants International Journal of Antimicrobial Agents ·Na Liu,Xiaohong Wang,Jixiang Zhu,Sumit Basu,Yudong Wei,Jelena MLADENOVİC,Hui Wang,Francheska Colón‐González,Hwa-ping Feng,Ángeles Quezada,Haiyan Li,丽娜潘	2023	2
2	Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants Clinical Pharmacology in Drug Development ·Andrea Cabot Echevarría,Yang Liu,María José Oros Soto,Terry O’Reilly,Francheska Colón‐González,Evan Friedman,Mallika Lala,Elizabeth G. Rhee,Matthew L. Rizk	2020	3
3	A Single- and Multiple-Dose Study To Characterize the Pharmacokinetics, Safety, and Tolerability of Imipenem and Relebactam in Healthy Chinese Participants Antimicrobial Agents and Chemotherapy ·Xiaohong Wang,Na Liu,Yudong Wei,Shuang Zhang,Haiyan Li,Jelena MLADENOVİC,Munjal Patel,Hui Wang,Andrea Cabot Echevarría,Francheska Colón‐González,丽娜潘,Abhigyan Bhasin	2020	0
4	Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults Clinical and Translational Science ·Robert E. Typanski,Walter K. Kraft,帝京平成大学,Francheska Colón‐González,Wen Liu,Jialin Xu,Deborah Panebianco,Lori Mixson,Marissa F. Dockendorf,Catherine Z. Matthews,Ramesh Boinpally	2020	26
5	Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin British Journal of Clinical Pharmacology ·María José Oros Soto,Francheska Colón‐González,Yang Liu,Jin Wu,Shiyao Xu,Micaël Aguedjou,Patricia Jumes,Kenneth C. Lasseter,Thomas Marbury,Matthew L. Rizk,Mallika Lala,Elizabeth G. Rhee,Joan R. Butterton,Andrea Cabot Echevarría	2019	11
6	Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants Antimicrobial Agents and Chemotherapy ·Elizabeth G. Rhee,Matthew L. Rizk,Nicole Calder,Ahood Mahjari,Steve Warrington,Michael S. Schwartz,Eric Mangin,Andrea Cabot Echevarría,María José Oros Soto,Francheska Colón‐González,Patricia Jumes,Yang Liu,Joan R. Butterton	2018	42
7	Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis Cancer Research ·Jieru E. Lin,Francheska Colón‐González,Erik Blomain,Gilbert W. Kim,Azusa Akimoto,Ahmed Bedawy,Petra Neugebauer,Adam E. Snook,Tingting Zhan,Terry Hyslop,Michal Tomczak,Richard S. Blumberg,Scott A. Waldman	2016	47
8	Abstract 2882: Calorie-induced silencing of the tumor suppressive guanylin-GUCY2C paracrine axis underlies colorectal cancer in obesity Cancer Research ·Erik Blomain,Jieru E. Lin,Francheska Colón‐González,Gilbert W. Kim,Terry Hyslop,Tingting Zhan,Adam E. Snook,Scott A. Waldman	2015	1
9	No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil Biology of Blood and Marrow Transplantation ·William L. Marshall,Cyrus Badshah,Oksana Ivanivna Strachar,Walter K. Kraft,Francheska Colón‐González,Arne van Schanke,Sita Dhimal,Bhavna Kantesaria,Ellen G. J. Hulskotte,尊俊長手,Joan R. Butterton,Eugene E. Marcantonio	2015	2
10	Coordinated activation of the Rac-GAP β2-chimaerin by an atypical proline-rich domain and diacylglycerol Nature Communications ·Álvaro Gutiérrez-Uzquiza,Francheska Colón‐González,Thomas A. Leonard,Bertram Canagarajah,Hongbin Wang,Bruce J. Mayer,James H. Hurley,Marcelo G. Kazanietz	2013	11
11	GUCY2C at the intersection of obesity and colorectal cancer BMC Pharmacology and Toxicology ·Scott A. Waldman,Jieru E. Lin,Francheska Colón‐González,Adam E. Snook,Michael Valentino,Gilbert Kim,Erik Blomain,Terry Hyslop	2013	2
12	Obesity pharmacotherapy: What is next? Molecular Aspects of Medicine ·Francheska Colón‐González,Gilbert W. Kim,Jieru E. Lin,Michael Valentino,Scott A. Waldman	2012	47
13	Regulation of appetite to treat obesity Expert Review of Clinical Pharmacology ·Gilbert W. Kim,Jieru E. Lin,Michael Valentino,Francheska Colón‐González,Scott A. Waldman	2011	35
14	Pharmacokinetic evaluation of fosaprepitant dimeglumine Expert Opinion on Drug Metabolism & Toxicology ·Francheska Colón‐González,Walter K. Kraft	2010	24
15	Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity Expert Review of Endocrinology & Metabolism ·Michael Valentino,Francheska Colón‐González,Jieru E. Lin,Scott A. Waldman	2010	2
16	A Novel Cross-talk in Diacylglycerol Signaling Journal of Biological Chemistry ·Erin Griner,M. Cecilia Caino,María Soledad Sosa,Francheska Colón‐González,Michael J. Chalmers,Harald Mischak,Marcelo G. Kazanietz	2010	17
17	Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP α2-Chimaerin Journal of Biological Chemistry ·Francheska Colón‐González,Federico Coluccio Leskow,Marcelo G. Kazanietz	2008	23
18	Effect of Polymer Amphiphilicity on Loading of a Therapeutic Enzyme into Protective Filamentous and Spherical Polymer Nanocarriers Biomacromolecules ·Eric Simone,Thomas D. Dziubla,Francheska Colón‐González,Dennis E. Discher,Vladimir R. Muzykantov	2007	45
19	C1 domains exposed: From diacylglycerol binding to protein–protein interactions Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Francheska Colón‐González,Marcelo G. Kazanietz	2006	256

About Francheska Colón‐González

Francheska Colón‐González is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrine and Autonomic Systems, having authored 19 papers that have together received 596 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (3 papers), Regulation of Appetite and Obesity (3 papers), Pneumonia and Respiratory Infections (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pharmacology and Obesity Treatment (2 papers), Antibiotic Use and Resistance (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Molecular Medicine (52 citations) and Endocrine and Autonomic Systems (41 citations). Francheska Colón‐González has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Marcelo G. Kazanietz, Jieru E. Lin, Scott A. Waldman, Gilbert W. Kim, Michael Valentino, Walter K. Kraft, Dennis E. Discher, Thomas D. Dziubla, Vladimir R. Muzykantov and Eric Simone. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Cancer Research, Nature Communications and Molecular Aspects of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact